Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

19 févr. 2026 10h51 HE | Source: Research and Markets

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline Market Research Report 2026: Soliris and Ultomiris from AstraZeneca and Piasky Have Set the Stage for Next Generation Biosuperiors

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Complement C5 Inhibitors & C5 Receptor Antagonists" report has been added to ResearchAndMarkets.com's offering.This competitive...
19 févr. 2026 10h48 HE | Source: Research and Markets

Claudin 18.2-Targeted Immunotherapy Pipeline Market Research Report 2026: an Up-to-date Competitor Evaluation in the Field of Therapy Candidates in Research and Development

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Claudin 18.2-Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
19 févr. 2026 10h46 HE | Source: Research and Markets

CD47 and SIRP-alpha Targeted Immunotherapy Pipeline Research Report 2026: More Than 20 Distinct Molecules Targeting the CD47-SIRP-a Pathway are in Clinical Development

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of CD47 and SIRP-alpha Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
19 févr. 2026 09h39 HE | Source: Research and Markets

Cancer & Antibody Conjugates Patent Landscape Analysis 2025: 3761 Patent Families - IP Trends, Including Time Evolution of Published Patents and Countries of Patent Filings

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Cancer & Antibody Conjugates Patent Landscape Analysis 2025" report has been added to ResearchAndMarkets.com's offering.Key Features: PDF >...
18 févr. 2026 10h47 HE | Source: Research and Markets

TIGIT Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 18+ Companies and 20+ Drugs

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "TIGIT Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report presents in-depth insights into...
18 févr. 2026 10h45 HE | Source: Research and Markets

PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 200+ Drugs from Over 180 Companies by Company, Product Type, Stage, Route of Administration, and Molecule Type

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers exhaustive...
18 févr. 2026 10h32 HE | Source: Research and Markets

Monoclonal Antibodies Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 230+ Drugs by Company, Product, Stage of Development, Route of Administration, Molecule Type

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers a detailed analysis...
18 févr. 2026 10h21 HE | Source: Research and Markets

Ebola Virus Competitive Landscape Report 2026: Comprehensive Insights About 18+ Companies and 20+ Drugs

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Ebola Virus - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The comprehensive report on the "Ebola Virus...
17 févr. 2026 10h13 HE | Source: Research and Markets

Immunotherapy Drugs Market Research and Forecast Report, 2020-2025/2025-2026 with Analyst Recommendations - Adoption of AI in Drug Discovery / Combination Therapies

Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market (2026 Edition)" report has been added to ResearchAndMarkets.com's offering.The global immunotherapy drugs market is...
10 févr. 2026 04h05 HE | Source: Research and Markets

Claudin 18.2 Targeted Therapy Market Research 2026: Astellas' Zolbetuximab Leads Gastric Cancer Progress, While Servier Pharmaceuticals and Others Expand ADC and CAR-T Strategies - Forecasts to 2030

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Claudin 18.2 Targeted Therapy Market Opportunity, Therapeutic Approaches, Approved Drug Price, Sales and Clinical Trials Insight 2030" report has been...

Page suivante